Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Theragene Pharmaceuticals, Inc. announced it raised $200,000 in an initial filing from an offering of $30 Million
PRIVATEAug 11, 2015•about 11 years ago
Amount Raised
$200,000
Round Type
Pre-Seed
CaliforniaBiotechnologyDon't miss Theragene Pharmaceuticals, Inc.'s next move
Get an email the moment Theragene Pharmaceuticals, Inc. raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Theragene Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.